Page last updated: 2024-09-03

pentosidine and Prostatic Neoplasms

pentosidine has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ito, K; Koike, H; Matsui, H; Miyazawa, Y; Nomura, M; Sekine, Y; Shibata, Y; Suzuki, K; Syuto, T	1

Other Studies

1 other study(ies) available for pentosidine and Prostatic Neoplasms

Article	Year
Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab. Anticancer research, 2017, Volume: 37, Issue:7 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Arginine; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Femur Neck; Fractures, Bone; Humans; Lumbar Vertebrae; Lysine; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Retrospective Studies; Tartrate-Resistant Acid Phosphatase	2017

Article

Year

Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.

Anticancer research, 2017, Volume: 37, Issue:7

Topics: Aged; Aged, 80 and over; Androgen Antagonists; Arginine; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Femur Neck; Fractures, Bone; Humans; Lumbar Vertebrae; Lysine; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Retrospective Studies; Tartrate-Resistant Acid Phosphatase

2017